FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 05/07/2020 |
3. Issuer Name and Ticker or Trading Symbol
JELD-WEN Holding, Inc. [ JELD ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 172,719(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Common Stock Option (Right to Buy) | (2) | 02/26/2028 | Common Stock Option (Right to Buy) | 11,137 | $33.34 | D | |
Common Stock Option (Right to Buy) | (2) | 02/25/2029 | Common Stock Option (Right to Buy) | 15,396 | $20.96 | D | |
Common Stock Option (Right to Buy) | (2) | 02/11/2030 | Common Stock Option (Right to Buy) | 15,873 | $24.54 | D |
Explanation of Responses: |
1. The reported transaction includes the following awards made in respect of the issuer's common stock, the vesting of which is subject to the reporting person's continued employment with the issuer: (i) 15,000 restricted stock units granted on February 1, 2018, which shall vest on February 1, 2021, (ii) 15,000 restricted stock units granted on February 1, 2018, which shall vest on February 1, 2022, (iii) 4,339 restricted stock units granted on February 26, 2018, which shall vest on February 26, 2021, (iv) 6,118 restricted stock units granted on February 25, 2019, which shall vest on February 25, 2022, (v) 14,262 restricted stock units granted on February 11, 2020, which shall vest on February 11, 2023, and (vi) 118,000 restricted stock units granted on March 23, 2020, which shall vest one-third annually over a three-year period beginning on the first anniversary of the grant date. |
2. Subject to the reporting person's continued employment with the issuer, the options will vest one-third annually over a three-year period beginning on the first anniversary of the grant date. |
Remarks: |
/s/ Daniel J Castillo | 05/18/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |